Tweet Now the title of this post seemingly has nothing to do with the content of the paper, but what this new paper says is air poluution is bad for you. We say NSS. However is it the air pollution that is the issue or is it something that is more causal, but relates to…
M&M: Merck, Mayo Clinic team up to use AI to speed drug development in MS
Merck and Mayo Clinic have launched a research collaboration to use artificial intelligence (AI) and large-scale clinical data to accelerate drug discovery and development, with an initial focus on diseases with high unmet needs, including multiple sclerosis (MS). The partnership will combine Mayo’s extensive clinical and genomic datasets with Merck’s AI-enabled research technologies. The Merck…
Connection and Compassion: My MS Journey
By Dr. Eva Jackson Seeking Answers and Facing Uncertainty For many years, my health declined, and I found myself searching desperately for answers. Ireached out to my healthcare team, at times pleading for their help to uncover what was causingmy … Continue reading → Source: blog.mymsaa.org
Childhood bacteria..was does it tell us about the cause of MS.
Tweet mmmmM…my favourite subject….Yep my Bad…I don’t know the back end of a flagelleum from the front end…So I will do like every respecting cheat and use AI rather than reading and ask it to tell me what the important bacteria in MS are. Here is the answer (from Google) “Multiple sclerosis (MS) is associated…
Measuring oligoclonal bands. Is it more an art than a science…No wonder people want a more useful alternative
Tweet Higgins V, Parker ML, Ahmed B, Bhayana V, Booth RA, Chen Y, Collier C, Freedman MS, Gagné M, Ismail OZ, Gifford JL, Macri J, Moore CS, Newbigging A, Olayinka L, Poliakov I, Rodriguez-Capote K, Schneider R, Thebault S, Yang L, Beriault DR. Best practice recommendations for laboratory analysis and reporting of cerebrospinal fluid oligoclonal…
Early effective therapy is the Answer. If not what’s the question
Tweet Alroughani R, Ahmed SF. Treatment outcomes of high-efficacy disease-modifying therapies in patients with relapsing-remitting multiple sclerosis: A longitudinal observational study. Mult Scler Relat Disord. 2026 Jan 19;108:107024. doi: 10.1016/j.msard.2026.107024. Epub ahead of print. Background: The evolution of high-efficacy disease-modifying therapies (HE-DMTs) has significantly shifted the management of relapsing-remitting multiple sclerosis (RRMS). Real-world evidence highlighted the…
MS patients see lasting benefits from Briumvi treatment, study says
Continued treatment with TG Therapeutics’ Briumvi (ublituximab) provides sustained clinical benefits for people with relapsing forms of multiple sclerosis (MS), particularly if started earlier. That’s according to data from the ULTIMATE I (NCT03277261) and ULTIMATE II (NCT03277248) Phase 3 clinical trials and their ongoing open-label extension (NCT04130997). After five years of follow-up, more than 80%…
Intention & Expectations
By Stacie Prada Lately, I’ve been pausing periodically throughout each day to ask myself, “How do I want to show up today?” It only takes a moment, just enough time for a brief inhale and exhale. It allows me to … Continue reading → Source: blog.mymsaa.org
Remyelination in Monkeys with Clemastine
Tweet In the UK people have a real issue with non-human primate research and there is essentially no MS related work ongoing in the UK. You know we love our furry friends and in the 1980s when I worked in a place where people worked on marmosets and Epstein Barr Virus, they used to have…
It may not always look like it, but I’m not giving up
Several (OK, many) years ago, I was having lunch with a group of fellow Green Berets when a news story appeared on the TV. The report covered a recent tragedy, and during an interview with a survivor, it was mentioned that one of the victims had not survived because they had “given up.” This sparked…